Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:06 AM
Ignite Modification Date:
2025-12-25 @ 4:06 AM
NCT ID:
NCT00237302
Eligibility Criteria:
Inclusion Criteria:
* Children who have had several attacks of headaches that meet the International Headache Society Classification of pediatric migraine with or without aura (for example, headache lasts up to 48 hours, has a throbbing quality, is accompanied by nausea or sensitivity to light, is made worse by physical activity)
* Average of 3 to 10 migraine days per month for previous 3 months
* Weighs more than 20 kilograms (44 pounds)
* Able to swallow a tablet whole (without crushing it)
Exclusion Criteria:
* Took topiramate previously to prevent migraines but it was not effective
* Had to stop taking topiramate because of side effects
* Presence of cluster headaches, migraine aura without headache
* Had taken any medications for migraine prevention within 2 weeks before study start
* Presence of active liver disease or abnormal kidney function
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
6 Years
Maximum Age:
15 Years
Study:
NCT00237302
Study Brief:
Protocol Section:
NCT00237302